Find clinical trials for Triple Negative Breast Cancer in Tampa, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Tampa, FL, USA:
inhibitor as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study...
Phase 1
Tampa, Florida, United States and 4 other locations
with stereotactic radiation (SRS) in participants with metastatic triple negative breast cancer with brain metast...
Phase 1, Phase 2
Tampa, Florida, United States
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Tampa, Florida, United States and 23 other locations
The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patie...
Phase 1
Tampa, Florida, United States and 20 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Tampa, Florida, United States and 372 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Tampa, Florida, United States and 374 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Tampa, Florida, United States and 506 other locations
This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 will be a single-arm study of intratumoral tavokinogene telseplasmid (TAVO)...
Phase 2
Tampa, Florida, United States and 13 other locations
This study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated d...
Phase 1, Phase 2
Tampa, Florida, United States and 12 other locations
A study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) an...
Phase 1
Tampa, Florida, United States and 28 other locations
Clinical trials
Research sites
Resources
Legal